amy s. rosenberg
Office of Biotechnology Products, Division of Biotechnology Review and Research III (DBRRIII), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), FDA
United States
23k
Total downloads
73k
Total views and downloads
Select the journal/section where you want your idea to be submitted:
Office of Biotechnology Products, Division of Biotechnology Review and Research III (DBRRIII), Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), FDA
United States
Aix Marseille Univ, INSERM, CRO2, Centre de Recherche en Oncologie biologique et Oncopharmacologie
France
Aix Marseille Univ, INSERM, CRO2, Centre de Recherche en Oncologie biologique et Oncopharmacologie
France
Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy
France
Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
China
Department of Medical Oncology, Centre Georges François Leclerc
France
Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
China
Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
China
Department of Microbiology, Icahn School of Medicine at Mount Sinai
United States
Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology
China
Facility for Biotechnology Resources, Center for Biologics Evaluation and Research (CBER), FDA
United States
Department of Medical Oncology, Centre Georges François Leclerc
France
Frontiers in Oncology